TY - JOUR
T1 - Disease burden, risk factors, and temporal trends of eye cancer
T2 - a global analysis of cancer registries
AU - Huang, Junjie
AU - Chan, Sze Chai
AU - Ko, Samantha
AU - Lok, Veeleah
AU - Zhang, Lin
AU - Lin, Xu
AU - Lucero-Prisno, Don Eliseo
AU - Xu, Wanghong
AU - Zheng, Zhi-Jie
AU - Elcarte, Edmar
AU - Withers, Mellissa
AU - Wong, Martin C.S.
AU - NCD Global Health Research Group
AU - Association of Pacific Rim Universities (APRU)
N1 - Publisher Copyright:
© 2024 The Authors. Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists.
PY - 2024/5
Y1 - 2024/5
N2 - Background: This study aims to investigate the global disease burden, risk factors, and temporal trends of eye cancer by sex and age group. Methods: Databases including Cancer Incidence in Five Continents volumes I–XI, the Nordic Cancer Registries, the Surveillance, Epidemiology, and End Results Program and the WHO IARC mortality database were accessed to extract incidence and mortality data. Joinpoint regression analyses were conducted to evaluate the Average Annual Percentage Change of the incidence and mortality. Results: The age-standardised rates of eye cancer incidence and mortality were 0.49 and 0.08 globally in 2020. Higher incidence rates were observed in Sub-Saharan Africa (ASR = 4.06), Western Europe (ASR = 0.89), and Northern Europe (ASR = 0.84), but higher mortality was observed only in Sub-Saharan Africa (ASR = 1.59). Lower HDI, higher prevalence of UV exposure and lower prevalence of several lifestyle habits and metabolic syndromes were associated with higher incidence and mortality. There was an overall stable incidence trend and a decreasing mortality trend. Notably, all countries reporting decreasing trend in mortality were in the Asian or European region. Conclusions: Although higher incidence was observed in both African and European regions, only the Sub-Saharan Africa region reported high mortality, indicating inequity in the access of healthcare and treatment resource. Higher prevalence of UV exposure was associated with both higher incidence and mortality. Education should be provided to increase the awareness of eye protection. An overall declining mortality trend was found, but it was limited to only Asian and European countries.
AB - Background: This study aims to investigate the global disease burden, risk factors, and temporal trends of eye cancer by sex and age group. Methods: Databases including Cancer Incidence in Five Continents volumes I–XI, the Nordic Cancer Registries, the Surveillance, Epidemiology, and End Results Program and the WHO IARC mortality database were accessed to extract incidence and mortality data. Joinpoint regression analyses were conducted to evaluate the Average Annual Percentage Change of the incidence and mortality. Results: The age-standardised rates of eye cancer incidence and mortality were 0.49 and 0.08 globally in 2020. Higher incidence rates were observed in Sub-Saharan Africa (ASR = 4.06), Western Europe (ASR = 0.89), and Northern Europe (ASR = 0.84), but higher mortality was observed only in Sub-Saharan Africa (ASR = 1.59). Lower HDI, higher prevalence of UV exposure and lower prevalence of several lifestyle habits and metabolic syndromes were associated with higher incidence and mortality. There was an overall stable incidence trend and a decreasing mortality trend. Notably, all countries reporting decreasing trend in mortality were in the Asian or European region. Conclusions: Although higher incidence was observed in both African and European regions, only the Sub-Saharan Africa region reported high mortality, indicating inequity in the access of healthcare and treatment resource. Higher prevalence of UV exposure was associated with both higher incidence and mortality. Education should be provided to increase the awareness of eye protection. An overall declining mortality trend was found, but it was limited to only Asian and European countries.
KW - disease burden
KW - eye cancer
KW - risk factor
KW - temporal trend
UR - http://www.scopus.com/inward/record.url?scp=85183609137&partnerID=8YFLogxK
U2 - 10.1111/ceo.14353
DO - 10.1111/ceo.14353
M3 - Article
C2 - 38281507
AN - SCOPUS:85183609137
SN - 1442-6404
VL - 52
SP - 440
EP - 451
JO - Clinical & Experimental Ophthalmology
JF - Clinical & Experimental Ophthalmology
IS - 4
ER -